#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoinflammation with infantile enterocolitis Thrombocytosis Ureteric cancer Anti-myelin-associated glycoprotein antibodies positive Retinal artery occlusion Bronchopulmonary aspergillosis Alexander disease Prolymphocytic leukaemia Immune-mediated enterocolitis Carcinoid syndrome Chronic myelomonocytic leukaemia Congenital growth hormone deficiency Neuroendocrine cell hyperplasia of infancy Colon cancer Fallopian tube cancer More trials…

    Learn about Rare Diseases

    Cystic fibrosis – Trials in Disease Ewing’s sarcoma recurrent Familial haemophagocytic lymphohistiocytosis – Trials in Disease Systemic mastocytosis – Basic Information Retinoblastoma – Basic Information Antithrombin III deficiency – Basic Information Propionic acidaemia – Basic Information Choroid melanoma – Trials in Disease Propionic acidaemia – Diagnostics Gaucher’s disease type III – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ZALFERMIN Psilocybine Stro-002 Mercaptamine Oxytocin Synthetic Relebactam Db-Oto-5 Paracetamol Abc-23A-116 VGA039 FIBRIN Donanemab RP3 Danicopan Magrolimab Pioglitazone Hydrochloride Bp1.7881A Ficlatuzumab Ferric Carboxymaltose Crinecerfont More therapies…

    Learn about Your Condition

    Haemorrhage Endocarditis enterococcal Hyperoxaluria Eye disorder Necrotising myositis Fatty acid oxidation disorder Oedema peripheral Epileptic encephalopathy Duchenne muscular dystrophy Oesophageal disorder Rheumatic disorder Agitation postoperative Endolymphatic hydrops Shprintzen-Goldberg syndrome Pustular psoriasis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Aortic valve stenosis

  • Study on Icosapent Ethyl for Slowing Aortic Valve Stenosis Progression in Patients with Aortic Valve Stenosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Aortic valve stenosis
    Investigated Drugs:
    • Icosapent Ethyl
    The Netherlands

  • Study on Short vs. Long Antiplatelet Therapy with Aspirin for Adults After TAVI for Symptomatic Aortic Stenosis

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Aortic valve stenosis
    Investigated Drugs:
    • D,L-Lysine Acetylsalicylate
    • Acetylsalicylic Acid
    France

  • Study on Pelacarsen for Slowing Calcific Aortic Valve Stenosis in Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Aortic valve stenosis
    Investigated Drugs:
    • Pelacarsen
    Austria Belgium Czechia Denmark France Germany +4

  • Study on Personalized Antithrombotic Therapy with Acenocoumarol, Phenprocoumon, and Apixaban for Patients with Aortic Valve Stenosis Post-TAVI

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Aortic valve stenosis
    Investigated Drugs:
    • Acenocoumarol
    • D,L-Lysine Acetylsalicylate
    • Phenprocoumon
    Belgium Denmark France Germany The Netherlands

  • A Phase 2b/3 Randomized Double‑Blind Study of Ataciguat to Slow Disease Progression in Adults with Moderate Calcific Aortic Valve Stenosis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Aortic valve stenosis
    Austria Czechia France Norway Poland Portugal +1

  • Study of Colchicine Treatment to Slow Down Aortic Valve Stenosis Progression in Adult Patients with Moderate Disease

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Aortic valve disease
    • Aortic valve stenosis
    • Inflammation
    Investigated Drugs:
    • Colchicine
    The Netherlands
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!